Scientific research has identified several genetic variations known to influence the risk of developing skin cancer. The genetic test includes analysis of 18 genetic polymorphisms (ASIP rs1015362; ASIP rs4911414; CDK10 rs258322; CLPTM1L rs401681; MC1R rs11547464; MC1R rs1805005; MC1R rs1805006; MC1R rs1805007; MC1R rs1805009; MC1R rs2228479; MC1R rs885479; MTAP rs7023329; MYH7B rs1885120; NCOA6 rs4911442; PARP1 rs3219090; PIGU rs910873; SLC45A2 rs16891982; TYR rs1393350). Through these genetic analyses, individuals receive information about the risk of developing malignant melanoma (“black skin cancer”) and non-malignant melanoma (“light skin cancer”), as well as preventive measures. Additionally, as part of the genetic analysis, through the analysis of 11 genes, information is available on the effects of 27 medications, including their mechanism of action, rate of metabolism, and the required dose necessary to keep disease symptoms under control
303.00€